Your browser doesn't support javascript.
loading
Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study.
Chin, C K; Lim, K J; Lewis, K; Jain, P; Qing, Y; Feng, L; Cheah, C Y; Seymour, J F; Ritchie, D; Burbury, K; Tam, C S; Fowler, N H; Fayad, L E; Westin, J R; Neelapu, S S; Hagemeister, F B; Samaniego, F; Flowers, C R; Nastoupil, L J; Dickinson, M J.
  • Chin CK; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lim KJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Lewis K; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Jain P; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.
  • Qing Y; Medical School, University of Western Australia, Nedlands, Australia.
  • Feng L; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cheah CY; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Seymour JF; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ritchie D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.
  • Burbury K; Medical School, University of Western Australia, Nedlands, Australia.
  • Tam CS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Fowler NH; The University of Melbourne, Melbourne, Australia.
  • Fayad LE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Westin JR; The University of Melbourne, Melbourne, Australia.
  • Neelapu SS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Hagemeister FB; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Samaniego F; The University of Melbourne, Melbourne, Australia.
  • Flowers CR; St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dickinson MJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 191(5): 806-815, 2020 12.
Article en En | MEDLINE | ID: mdl-33065767
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reordenamiento Génico / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B de la Zona Marginal / Trasplante de Células Madre Hematopoyéticas / Tomografía de Emisión de Positrones / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reordenamiento Génico / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B de la Zona Marginal / Trasplante de Células Madre Hematopoyéticas / Tomografía de Emisión de Positrones / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article